Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Thomas J. Meade
Northwestern University, Department: Chemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
PreDx Corporation
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This research is to develop a series of hormone-based magnetic resonance imaging (MRI) contrast agents to facilitate molecular characterization of the status and function of steroid hormone receptors in hormone-dependent human disease. Professor Meade is a founder of PreDx, and discloses equity interest from the company, which has the goal of creating and using bioactivatable contrast agents for imaging diagnostics. Given the close relationship of the work and goals of PreDx and this proposal, continued development of these MRI contrast agents funded through this grant may result in a perceived conflict of interest that should be managed.
Steroid-Based Contrast Agents for Magnetic Resonance Imaging of Endocrine Disease
Steroid receptors have emerged as attractive targets for molecular imaging due to their role in promoting the growth of breast and uterine lesions. This proposal will develop steroid magnetic resonance imaging contrast agents that could provide a molecular profile of hormone receptor status in cells and tissues, validate responsiveness to therapy, and improve diagnoses. This is an innovative and far-reaching proposal that is likely to impact the fields of imaging, cancer diagnosis, and women's health.
Filed on January 25, 2013.
Tell us what you know about Thomas J. Meade's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.